Patent details
EP3677266 Title: EXON 18 AND/OR EXON 21 MUTANT EGFR SELECTIVE INHIBITOR
Basic Information
- Publication number:
- EP3677266
- PCT Application Number:
- JP2018032314
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP188515555
- PCT Publication Number:
- WO2019045036
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- EXON 18 AND/OR EXON 21 MUTANT EGFR SELECTIVE INHIBITOR
- French Title of Invention:
- INHIBITEUR SÉLECTIF DE L'EGFR MUTÉ SUR L'EXON 18 ET/OU SUR L'EXON 21
- German Title of Invention:
- EXON-18- UND/ODER EXON-21-MUTANTER EGFR-SELEKTIVER INHIBITOR
- SPC Number:
Dates
- Filing date:
- 31/08/2018
- Grant date:
- 17/01/2024
- EP Publication Date:
- 08/07/2020
- PCT Publication Date:
- 07/03/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 17/01/2024
- EP B1 Publication Date:
- 17/01/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 31/08/2024
- Expiration date:
- 31/08/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/01/2024
- Name:
- Taiho Pharmaceutical Co., Ltd.
- Address:
- 1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444, Japan (JP)
Inventor
1
- Name:
- HASAKO, Shinichi
- Address:
- Japan (JP)
2
- Name:
- ABE, Naomi
- Address:
- Japan (JP)
Priority
- Priority Number:
- 2017168606
- Priority Date:
- 01/09/2017
- Priority Country:
- Japan (JP)
Classification
- IPC classification:
- A61K 31/519; A61P 35/00; C12N 9/99;
Publication
European Patent Bulletin
- Issue number:
- 202403
- Publication date:
- 17/01/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|